Taufalele P, Kirkham H, Reinhart-King C
Cell Mol Bioeng. 2025; 18(1):29-38.
PMID: 39949487
PMC: 11813852.
DOI: 10.1007/s12195-024-00836-9.
Liu L, Han F, Deng M, Han Q, Lai M, Zhang H
Cell Death Differ. 2025; .
PMID: 39870803
DOI: 10.1038/s41418-025-01450-6.
Padzinska-Pruszynska I, Taciak B, Kiraga L, Smolarska A, Gorczak M, Kucharzewska P
Int J Mol Sci. 2025; 25(24.
PMID: 39769334
PMC: 11679359.
DOI: 10.3390/ijms252413569.
Ribatti D
Clin Exp Med. 2024; 24(1):227.
PMID: 39325128
PMC: 11427519.
DOI: 10.1007/s10238-024-01490-1.
Fan M, Xu X, Hu Y
Aging (Albany NY). 2024; 16(12):10252-10270.
PMID: 38870270
PMC: 11236301.
DOI: 10.18632/aging.205928.
Aberrant tumor vasculature. Facts and pitfalls.
Ribatti D
Front Pharmacol. 2024; 15:1384721.
PMID: 38576482
PMC: 10991687.
DOI: 10.3389/fphar.2024.1384721.
KLK10 derived from tumor endothelial cells accelerates colon cancer cell proliferation and hematogenous liver metastasis formation.
Kato K, Noda T, Kobayashi S, Sasaki K, Iwagami Y, Yamada D
Cancer Sci. 2024; 115(5):1520-1535.
PMID: 38475666
PMC: 11093189.
DOI: 10.1111/cas.16144.
Endothelial cells in tumor microenvironment: insights and perspectives.
Leone P, Malerba E, Susca N, Favoino E, Perosa F, Brunori G
Front Immunol. 2024; 15:1367875.
PMID: 38426109
PMC: 10902062.
DOI: 10.3389/fimmu.2024.1367875.
Acquisition of drug resistance in endothelial cells by tumor-derived extracellular vesicles and cancer progression.
Morimoto M, Maishi N, Hida K
Cancer Drug Resist. 2024; 7:1.
PMID: 38318528
PMC: 10838380.
DOI: 10.20517/cdr.2023.121.
Viral uptake and pathophysiology of the lung endothelial cells in age-associated severe SARS-CoV-2 infection models.
Tsumita T, Takeda R, Maishi N, Hida Y, Sasaki M, Orba Y
Aging Cell. 2023; 23(2):e14050.
PMID: 38098255
PMC: 10861199.
DOI: 10.1111/acel.14050.
Oral bacterium Streptococcus mutans promotes tumor metastasis through thrombosis formation.
Yu L, Hong Y, Maishi N, Matsuda A, Hida Y, Hasebe A
Cancer Sci. 2023; 115(2):648-659.
PMID: 38096871
PMC: 10859626.
DOI: 10.1111/cas.16010.
Low-dose metronomic cisplatin as an antiangiogenic and anti-inflammatory strategy for cancer.
Kikuchi H, Maishi N, Yu L, Jia Z, Li C, Sato M
Br J Cancer. 2023; 130(2):336-345.
PMID: 38036665
PMC: 10803316.
DOI: 10.1038/s41416-023-02498-2.
Methylation across the central dogma in health and diseases: new therapeutic strategies.
Liu R, Zhao E, Yu H, Yuan C, Abbas M, Cui H
Signal Transduct Target Ther. 2023; 8(1):310.
PMID: 37620312
PMC: 10449936.
DOI: 10.1038/s41392-023-01528-y.
The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican.
Berdiaki A, Giatagana E, Tzanakakis G, Nikitovic D
Cancers (Basel). 2023; 15(14).
PMID: 37509212
PMC: 10377491.
DOI: 10.3390/cancers15143549.
Tumour associated endothelial cells: origin, characteristics and role in metastasis and anti-angiogenic resistance.
Yao X, Zeng Y
Front Physiol. 2023; 14:1199225.
PMID: 37389120
PMC: 10301839.
DOI: 10.3389/fphys.2023.1199225.
Beyond starving cancer: anti-angiogenic therapy.
Hida K, Maishi N, Matsuda A, Yu L
J Med Ultrason (2001). 2023; 51(4):605-610.
PMID: 37170042
PMC: 11499530.
DOI: 10.1007/s10396-023-01310-1.
miR-1246 in tumor extracellular vesicles promotes metastasis increased tumor cell adhesion and endothelial cell barrier destruction.
Morimoto M, Maishi N, Tsumita T, Alam M, Kikuchi H, Hida Y
Front Oncol. 2023; 13:973871.
PMID: 37124539
PMC: 10130374.
DOI: 10.3389/fonc.2023.973871.
Angiogenic inhibitor pre-administration improves the therapeutic effects of immunotherapy.
Sato M, Maishi N, Hida Y, Yanagawa-Matsuda A, Alam M, Sakakibara-Konishi J
Cancer Med. 2023; 12(8):9760-9773.
PMID: 36808261
PMC: 10166916.
DOI: 10.1002/cam4.5696.
Unusual Suspects: Bone and Cartilage ECM Proteins as Carcinoma Facilitators.
Sorvina A, Antoniou M, Esmaeili Z, Kochetkova M
Cancers (Basel). 2023; 15(3).
PMID: 36765749
PMC: 9913341.
DOI: 10.3390/cancers15030791.
Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis.
Nallasamy P, Nimmakayala R, Parte S, Are A, Batra S, Ponnusamy M
Mol Cancer. 2022; 21(1):225.
PMID: 36550571
PMC: 9773588.
DOI: 10.1186/s12943-022-01682-x.